OpenAI has unveiled a custom AI chip co-designed with Broadcom, marking a direct move to build proprietary silicon and reduce dependence on NVIDIA's GPUs. This creates an AVGO/NVDA tension trade — AVGO as custom-silicon beneficiary, NVDA facing a headline overhang on its largest AI customer's diversification.
OpenAI has unveiled a custom AI chip co-designed with Broadcom, marking a direct move to build proprietary silicon and reduce dependence on NVIDIA's GPUs.
The OpenAI-Broadcom custom chip announcement puts AVGO and NVDA on opposite sides of the same trade — does AVGO's ASIC win signal durable share gains, or does NVDA's CUDA moat and training dominance make the overhang a buying opportunity?
NVDA's CUDA ecosystem and training dominance mean any news that OpenAI's custom chip is 'inference only' or delayed collapses the short leg; additionally, a broader AI infrastructure capex beat from any hyperscaler lifts both names and kills the spread.
CoverageSource: Investing.com · Published here WED, JUN 24 · 11:44 AM ET · 3 outlets in this record · latest listed: TechCrunch at 11:44 AM ETHow this is decided →
OpenAI has announced a custom AI accelerator chip designed in partnership with Broadcom, its first significant step toward vertically integrating its own silicon stack. The move follows a broader industry trend of hyperscalers — Google (TPU), Amazon (Trainium/Inferentia), and Microsoft (Maia) — developing proprietary chips to reduce unit economics dependency on NVIDIA's H100/H200 GPUs, which command premium pricing backed by CUDA lock-in.
For Broadcom, the deal is a meaningful revenue validation of its ASIC/custom-silicon strategy. AVGO has been building out its custom AI accelerator business (XPUs) for Google and Meta, and adding OpenAI as a named client confirms that Broadcom's design-and-supply model is scaling. NVIDIA, meanwhile, faces a symbolic and potentially structural headwind: OpenAI is reportedly one of its largest single GPU customers, spending billions annually on H-series chips.
The second-order tension is whether this is a long-term volume threat to NVDA or simply additive demand. Custom chips typically handle inference workloads more efficiently, while NVIDIA retains dominance in frontier model training. OpenAI will still need NVDA GPUs for training next-generation models even as it deploys its own chips for inference at scale.
NVDA's enrichment data shows extraordinary fundamentals — $215.9B revenue at +65.5% YoY growth, 71.1% gross margins, $4.90 diluted EPS — making it expensive to short on fundamentals alone. The real question is whether this headline accelerates a re-rating of NVDA's customer concentration risk. Watch AVGO for a near-term pop and NVDA for whether the market treats this as a structural de-rating event or a one-day headline fade.
AVGO's custom-silicon (XPU) franchise just added OpenAI as a named client alongside Google and Meta, directly validating its ASIC revenue thesis and likely triggering upward estimate revisions. NVDA faces a headline overhang on customer diversification away from GPU dependence, though its $215.9B revenue base and 71.1% gross margins reflect a business far more durable than a single customer news cycle. The pair trade — long AVGO / short NVDA — captures the sentiment rotation without requiring a structural NVDA collapse.
The read above, as written. kept as written · closes shown from JUN 24 on
1-3 weeks, near-term sentiment window. Follow to be told when one lands.
Price context does not establish that the story caused the move.
AVGO's XPU revenue line is growing rapidly with Google and Meta already onboard, and adding OpenAI as a custom-chip customer sets up meaningful consensus estimate upgrades in the next analyst cycle.
NVDA's +65.5% YoY revenue growth and 71.1% gross margins suggest its GPU franchise is structurally entrenched, and OpenAI's custom chip likely targets inference workloads only — leaving NVDA's training GPU dominance untouched for the foreseeable future.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
Shares a name with this story — discovery, not a connection.
This page is kept as it was written on Jun 24. Later coverage joins it only when the company and catalyst evidence match, and what the stock did is shown from licensed end-of-day closes — never re-graded, never backdated. The judgment is yours.